Report Detail

Other Global Hydroxyapatite-coated Femoral Components Market Insights, Forecast to 2025

  • RnM2946003
  • |
  • 07 March, 2019
  • |
  • Global
  • |
  • 114 Pages
  • |
  • QYResearch
  • |
  • Other

Hydroxyapatite-coated Femoral Components refers to a hard tissue implant material coated with hydroxyapatite on femur components using titanium as a base and physically and chemically. After the material is implanted into the human body, the titanium alloy can provide sufficient mechanical strength, the surface of the hydroxyapatite coating is easy to combine with the human bone, in the human bone surface induced new bone formation, generally months to induce new bone formation.
In the last several years, global market of hydroxyapatite-coated femoral components developed rapidly, with an average growth rate of 6.52%. In 2015, global revenue of hydroxyapatite-coated femoral components is nearly 985.5 M USD; the actual production is about 737.4 K Unit.
The global average price of hydroxyapatite-coated femoral components is in the decreasing trend, from 1375 USD/Unit in 2011 to 1336 USD/Unit in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of hydroxyapatite-coated femoral components includes primary, and revision. The proportion of primary in 2015 is about 65.5%, and the proportion is in increasing trend from 2011 to 2015.
The global Hydroxyapatite-coated Femoral Components market is valued at 1110 million US$ in 2018 and will reach 1830 million US$ by the end of 2025, growing at a CAGR of 6.5% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Hydroxyapatite-coated Femoral Components market based on company, product type, end user and key regions.

This report studies the global market size of Hydroxyapatite-coated Femoral Components in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hydroxyapatite-coated Femoral Components in these regions.
This research report categorizes the global Hydroxyapatite-coated Femoral Components market by top players/brands, region, type and end user. This report also studies the global Hydroxyapatite-coated Femoral Components market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Zimmer Biomet
Stryker
Nano Interface Technology
DePuy Synthes
Smith & Nephew
MicroPort
Exactech
Kycera Medical

Market size by Product
Primary
Revision
Market size by End User
Hospital
Clinic

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Hydroxyapatite-coated Femoral Components market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Hydroxyapatite-coated Femoral Components market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Hydroxyapatite-coated Femoral Components companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Hydroxyapatite-coated Femoral Components submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Hydroxyapatite-coated Femoral Components are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Hydroxyapatite-coated Femoral Components market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Hydroxyapatite-coated Femoral Components Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Hydroxyapatite-coated Femoral Components Market Size Growth Rate by Product
      • 1.4.2 Primary
      • 1.4.3 Revision
    • 1.5 Market by End User
      • 1.5.1 Global Hydroxyapatite-coated Femoral Components Market Size Growth Rate by End User
      • 1.5.2 Hospital
      • 1.5.3 Clinic
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Hydroxyapatite-coated Femoral Components Market Size
      • 2.1.1 Global Hydroxyapatite-coated Femoral Components Revenue 2014-2025
      • 2.1.2 Global Hydroxyapatite-coated Femoral Components Sales 2014-2025
    • 2.2 Hydroxyapatite-coated Femoral Components Growth Rate by Regions
      • 2.2.1 Global Hydroxyapatite-coated Femoral Components Sales by Regions
      • 2.2.2 Global Hydroxyapatite-coated Femoral Components Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Hydroxyapatite-coated Femoral Components Sales by Manufacturers
      • 3.1.1 Hydroxyapatite-coated Femoral Components Sales by Manufacturers
      • 3.1.2 Hydroxyapatite-coated Femoral Components Sales Market Share by Manufacturers
      • 3.1.3 Global Hydroxyapatite-coated Femoral Components Market Concentration Ratio (CR5 and HHI)
    • 3.2 Hydroxyapatite-coated Femoral Components Revenue by Manufacturers
      • 3.2.1 Hydroxyapatite-coated Femoral Components Revenue by Manufacturers (2014-2019)
      • 3.2.2 Hydroxyapatite-coated Femoral Components Revenue Share by Manufacturers (2014-2019)
    • 3.3 Hydroxyapatite-coated Femoral Components Price by Manufacturers
    • 3.4 Hydroxyapatite-coated Femoral Components Manufacturing Base Distribution, Product Types
      • 3.4.1 Hydroxyapatite-coated Femoral Components Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Hydroxyapatite-coated Femoral Components Product Type
      • 3.4.3 Date of International Manufacturers Enter into Hydroxyapatite-coated Femoral Components Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Hydroxyapatite-coated Femoral Components Sales by Product
    • 4.2 Global Hydroxyapatite-coated Femoral Components Revenue by Product
    • 4.3 Hydroxyapatite-coated Femoral Components Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Hydroxyapatite-coated Femoral Components Breakdown Data by End User

    6 North America

    • 6.1 North America Hydroxyapatite-coated Femoral Components by Countries
      • 6.1.1 North America Hydroxyapatite-coated Femoral Components Sales by Countries
      • 6.1.2 North America Hydroxyapatite-coated Femoral Components Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Hydroxyapatite-coated Femoral Components by Product
    • 6.3 North America Hydroxyapatite-coated Femoral Components by End User

    7 Europe

    • 7.1 Europe Hydroxyapatite-coated Femoral Components by Countries
      • 7.1.1 Europe Hydroxyapatite-coated Femoral Components Sales by Countries
      • 7.1.2 Europe Hydroxyapatite-coated Femoral Components Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Hydroxyapatite-coated Femoral Components by Product
    • 7.3 Europe Hydroxyapatite-coated Femoral Components by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Hydroxyapatite-coated Femoral Components by Countries
      • 8.1.1 Asia Pacific Hydroxyapatite-coated Femoral Components Sales by Countries
      • 8.1.2 Asia Pacific Hydroxyapatite-coated Femoral Components Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Hydroxyapatite-coated Femoral Components by Product
    • 8.3 Asia Pacific Hydroxyapatite-coated Femoral Components by End User

    9 Central & South America

    • 9.1 Central & South America Hydroxyapatite-coated Femoral Components by Countries
      • 9.1.1 Central & South America Hydroxyapatite-coated Femoral Components Sales by Countries
      • 9.1.2 Central & South America Hydroxyapatite-coated Femoral Components Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Hydroxyapatite-coated Femoral Components by Product
    • 9.3 Central & South America Hydroxyapatite-coated Femoral Components by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Hydroxyapatite-coated Femoral Components by Countries
      • 10.1.1 Middle East and Africa Hydroxyapatite-coated Femoral Components Sales by Countries
      • 10.1.2 Middle East and Africa Hydroxyapatite-coated Femoral Components Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Hydroxyapatite-coated Femoral Components by Product
    • 10.3 Middle East and Africa Hydroxyapatite-coated Femoral Components by End User

    11 Company Profiles

    • 11.1 Zimmer Biomet
      • 11.1.1 Zimmer Biomet Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Zimmer Biomet Hydroxyapatite-coated Femoral Components Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Zimmer Biomet Hydroxyapatite-coated Femoral Components Products Offered
      • 11.1.5 Zimmer Biomet Recent Development
    • 11.2 Stryker
      • 11.2.1 Stryker Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Stryker Hydroxyapatite-coated Femoral Components Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Stryker Hydroxyapatite-coated Femoral Components Products Offered
      • 11.2.5 Stryker Recent Development
    • 11.3 Nano Interface Technology
      • 11.3.1 Nano Interface Technology Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Nano Interface Technology Hydroxyapatite-coated Femoral Components Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Nano Interface Technology Hydroxyapatite-coated Femoral Components Products Offered
      • 11.3.5 Nano Interface Technology Recent Development
    • 11.4 DePuy Synthes
      • 11.4.1 DePuy Synthes Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 DePuy Synthes Hydroxyapatite-coated Femoral Components Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 DePuy Synthes Hydroxyapatite-coated Femoral Components Products Offered
      • 11.4.5 DePuy Synthes Recent Development
    • 11.5 Smith & Nephew
      • 11.5.1 Smith & Nephew Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Smith & Nephew Hydroxyapatite-coated Femoral Components Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Smith & Nephew Hydroxyapatite-coated Femoral Components Products Offered
      • 11.5.5 Smith & Nephew Recent Development
    • 11.6 MicroPort
      • 11.6.1 MicroPort Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 MicroPort Hydroxyapatite-coated Femoral Components Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 MicroPort Hydroxyapatite-coated Femoral Components Products Offered
      • 11.6.5 MicroPort Recent Development
    • 11.7 Exactech
      • 11.7.1 Exactech Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Exactech Hydroxyapatite-coated Femoral Components Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Exactech Hydroxyapatite-coated Femoral Components Products Offered
      • 11.7.5 Exactech Recent Development
    • 11.8 Kycera Medical
      • 11.8.1 Kycera Medical Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Kycera Medical Hydroxyapatite-coated Femoral Components Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Kycera Medical Hydroxyapatite-coated Femoral Components Products Offered
      • 11.8.5 Kycera Medical Recent Development

    12 Future Forecast

    • 12.1 Hydroxyapatite-coated Femoral Components Market Forecast by Regions
      • 12.1.1 Global Hydroxyapatite-coated Femoral Components Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Hydroxyapatite-coated Femoral Components Revenue Forecast by Regions 2019-2025
    • 12.2 Hydroxyapatite-coated Femoral Components Market Forecast by Product
      • 12.2.1 Global Hydroxyapatite-coated Femoral Components Sales Forecast by Product 2019-2025
      • 12.2.2 Global Hydroxyapatite-coated Femoral Components Revenue Forecast by Product 2019-2025
    • 12.3 Hydroxyapatite-coated Femoral Components Market Forecast by End User
    • 12.4 North America Hydroxyapatite-coated Femoral Components Forecast
    • 12.5 Europe Hydroxyapatite-coated Femoral Components Forecast
    • 12.6 Asia Pacific Hydroxyapatite-coated Femoral Components Forecast
    • 12.7 Central & South America Hydroxyapatite-coated Femoral Components Forecast
    • 12.8 Middle East and Africa Hydroxyapatite-coated Femoral Components Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Hydroxyapatite-coated Femoral Components Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Hydroxyapatite-coated Femoral Components . Industry analysis & Market Report on Hydroxyapatite-coated Femoral Components is a syndicated market report, published as Global Hydroxyapatite-coated Femoral Components Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Hydroxyapatite-coated Femoral Components market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,900.00
      $7,350.00
      $9,800.00
      3,782.80
      5,674.20
      7,565.60
      4,503.10
      6,754.65
      9,006.20
      745,143.00
      1,117,714.50
      1,490,286.00
      412,384.00
      618,576.00
      824,768.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report